Valneva: u.s. dod exercises first year option on ixiaro® supply contract

Saint herblain ( france), september 3 , 2021 – valneva se (nasdaq: valn; euronext paris: vla) a specialty vaccine company, today announced that the u.s. department of defense (dod) has exercised the first option of the contract signed in september 20201 to purchase further supply of its japanese encephalitis (je) vaccine ixiaro®.
VALN Ratings Summary
VALN Quant Ranking